HB 1261 bans PFAS chemicals (harmful substances linked to health risks) in firefighting protective gear, requiring safer alternatives for all new equipment. It creates grant programs to help fire companies replace PFAS-containing gear and mandates that state-funded equipment purchases must be PFAS-free. The bill also imposes penalties on entities failing to comply with the PFAS restrictions. These changes directly protect firefighters and guide fire companies' equipment procurement under Pennsylvania law.
SB 720 amends Pennsylvania's Public School Code to modify vision health requirements for school-aged children in public and nonpublic schools. It mandates that children receive a comprehensive eye health and vision examination by an ophthalmologist or optometrist before their first school admission, and again in fourth and eighth grades. The bill also requires an annual vision screening or eye examination. If a child fails a school-provided vision screening, a comprehensive eye health and vision examination becomes mandatory, to be completed within 120 days or before the next school year.
This Senate Resolution supports a federal bill that would create a three-year grant program to fund research and development of new treatments for veterans with chronic mild traumatic brain injury. The proposed grants would support academic institutions, healthcare providers, and community organizations in testing non-drug interventions, conducting clinical trials, training clinicians, and building partnerships to scale effective care strategies. The measure specifically aims to address mental health needs and suicide prevention among veterans, with Pennsylvania institutions encouraged to participate in the program. The resolution urges Congress to pass the federal legislation and calls for ongoing collaboration between state and federal officials to monitor and improve outcomes for veterans.
SB 402 amends Pennsylvania's Public School Code to allow trained school staff to administer emergency anti-seizure medication to students with epilepsy during seizures when a nurse is unavailable. It directly affects students with epilepsy, their parents/guardians (who must request training), and school employees (who may voluntarily undergo training). Key provisions require parental consent for staff training, mandate that participation be voluntary, and connect to existing disability laws (IDEA/Section 504) by encouraging schools to explore 504 plans or individualized health plans for affected students. The bill specifies that only FDA-approved medications (like nasal sprays) may be used, and trained staff must follow department-approved guidelines.
SB 507 amends Pennsylvania's medical licensing law to reestablish the State Board of Medical Education and Licensure as the State Board of Medicine and update its structure. It directly affects midwifery professionals by creating three new license categories: midwifery, nurse-midwife, and certified midwife. The bill establishes specific requirements and definitions for these licenses under the board's authority. This change clarifies licensing pathways for midwifery practitioners within the state's medical regulatory framework. The bill passed final passage on October 21, 2025.
SB 980 bans the manufacture, sale, and use of class B firefighting foam containing intentionally added PFAS chemicals after July 1, 2026 (for manufacturers/sellers) and January 1, 2027 (for users), with limited exceptions for federal requirements and exempt facilities like airports. It requires manufacturers of firefighting protective gear to label products containing PFAS and provide online information about PFAS content. The bill establishes civil penalties for violations (up to $5,000 for first offenses, $10,000 for repeat offenses) and creates new grant funding for fire companies to dispose of PFAS foam and purchase PFAS-free alternatives, with penalty revenue directed to these programs.
SB 1211 amends Pennsylvania's Insurance Company Law of 1921 to require casualty insurance policies to cover biomarker testing for medical assistance and Children's Health Insurance Program enrollees. The bill defines medical assistance and CHIP managed care plans as health care plans that use gatekeepers to manage services, explicitly including biomarker testing in this definition. This change ensures that insurance coverage for these specific health services is standardized under state law, subject to necessary federal approval. The legislation takes effect 60 days after passage.
SB 804 amends Pennsylvania's health and safety laws to ban the intentional addition of DEHP and certain ortho-phthalates (like BBP, DBP, DINP) in medical devices. It specifically targets intravenous (IV) solution containers (like IV bags) and IV tubing used in hospitals and healthcare facilities. The bill prohibits manufacturers from adding these chemicals to medical devices if they serve a functional purpose, requiring notice of such additions. This affects device manufacturers and healthcare facilities purchasing these products, directly changing manufacturing standards for common medical equipment.
SB 614 amends Pennsylvania's Fiscal Code to establish a state-funded initiative supporting workforce development for Federally Qualified Health Centers (FQHCs), which are community health centers serving rural and underserved areas. The bill directly affects FQHCs by providing funding to recruit and retain primary care staff, addressing documented shortages in these facilities. Key provisions include creating a dedicated funding stream within the state budget specifically for FQHC workforce expansion, with appropriations to cover hiring and training costs. This policy change aims to strengthen primary care access in communities with limited healthcare resources through targeted financial support.
SB 88 amends Pennsylvania's Insurance Company Law to require health insurance plans sold in the state to cover specific breast imaging services without cost-sharing for policyholders. It mandates annual mammograms for women 40+ and physician-recommended mammograms for women under 40, plus MRI and other breast imaging for those at average or higher risk of breast cancer due to factors like family history, genetic mutations, or dense breast tissue. The law specifies coverage for screening, supplemental, and diagnostic exams but does not require coverage for mastectomies or override standard deductibles/copays beyond the minimum required services. This replaces prior requirements that allowed cost-sharing and excluded MRI coverage.
